# Task

**User Story for Exploring Team Information on SFA Therapeutics Website**

As a potential investor interested in biotechnology innovations,
I learn more about the key personnel at SFA Therapeutics,
so that I can assess the team's qualifications and expertise before making an investment decision.

**Success definition:** Given I am on the SFA Therapeutics website
When I click on the TEAM link and then select Ira Spector's profile
Then I should see detailed information about Dr. Spector, including his role as CEO and co-founder, and his professional biography.

## Trajectory

**Step 1:**

**Url (before/after):** 

https://www.sfatherapeutics.com/

https://www.sfatherapeutics.com/

**Content (before/after):** 

```
RootWebArea HOME | Sfa Therapeutics 1, focused, url='https://www.sfatherapeutics.com/'
	region top of page
	button Skip to Main Content
	banner
		image Picture14.png, url='https://static.wixstatic.com/media/abea01_a79f1203843b4f1e869606561d1b7259~mv2.png/v1/crop/x_0,y_5,w_542,h_480/fill/w_99,h_88,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture14.png'
```
<details><summary>Show more</summary>

```
		image SFA Original Text.png, url='https://static.wixstatic.com/media/abea01_eddf156dbc904acf958c4ff6ba8dd10a~mv2.png/v1/crop/x_2,y_35,w_588,h_140/fill/w_332,h_79,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Original%20Text.png'
		heading TM
		navigation Site
			list
				listitem
					[115] link HOME, center=(520,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText HOME
				listitem
					[120] link ABOUT, center=(618,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText ABOUT
				listitem
					[125] link TEAM, center=(716,144), url='https://www.sfatherapeutics.com/team'
						paragraph
							StaticText TEAM
				listitem
					[130] link SCIENCE, center=(814,144), url='https://www.sfatherapeutics.com/science'
						paragraph
							StaticText SCIENCE
				listitem
					[135] link PLATFORM, center=(912,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText PLATFORM
				listitem
					[140] link PIPELINE, center=(1010,144), url='https://www.sfatherapeutics.com/pipeline'
						paragraph
							StaticText PIPELINE
				listitem
					[145] link CLINICAL, center=(1108,144), url='https://www.sfatherapeutics.com/clinical'
						paragraph
							StaticText CLINICAL
				listitem
					[150] link NEWS, center=(1206,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText NEWS
				listitem
					[158] link INVESTORS, center=(1304,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText INVESTORS
				listitem
					[163] link CONTACT, center=(1400,144), url='https://www.sfatherapeutics.com/contact'
						paragraph
							StaticText CONTACT
	main
		image, url='https://static.wixstatic.com/media/abea01_71c4bfa475cd4dca964663ebc6e5a564f000.jpg/v1/fill/w_1920,h_1080,al_c,q_90,usm_0.33_1.00_0.00,enc_avif,quality_auto/abea01_71c4bfa475cd4dca964663ebc6e5a564f000.jpg'
		heading NEXT  GENERATION  DRUGS  TO  TREAT AUTOIMMUNE,  CHRONIC   INFLAMMATORY   DISEASE AND  CANCER
			StaticText NEXT  GENERATION
			StaticText DRUGS  TO  TREAT
			StaticText AUTOIMMUNE,  CHRONIC   INFLAMMATORY   DISEASE
		heading ABOUT SFA THERAPEUTICS
			StaticText ABOUT SFA THERAPEUTICS
		paragraph
			StaticText Our journey began with a deep fascination for the intricate world of the human gut bacterial ecosystem and its profound impact on overall well-being.  Our founders, a team of passionate researchers and healthcare professionals, were intrigued by the pivotal role this complex microbiota plays in maintaining human health.  The various bacteria produce a complex, yet synergistic, set of metabolites in our intestines that exhibit profound, wide-ranging effects on metabolism and immune function.
		paragraph
			StaticText ​
			StaticText ​
		paragraph
			StaticText ​
			StaticText ​
		paragraph
			StaticText ​
			StaticText ​
		paragraph
			StaticText ​As we delved deeper into the science, we uncovered the potential of these biosynthetic molecules, that mimic naturally occurring substances, in addressing a variety of health challenges, from autoimmune disease to metabolic disorders. We were particularly captivated by how these simple organic compounds could influence complex cellular processes and serve as a communication bridge between our gut microbiome and immune system.
		paragraph
			StaticText ​
		paragraph
			StaticText ​
			StaticText ​
		paragraph
			StaticText ​
			StaticText ​
			StaticText ​
			StaticText ​
			StaticText ​
		paragraph
			StaticText We discovered ways of increasing the selectivity and specifictiy of our biosynthetics after elucidating pathways and targets.  We have developed a platform technology that allows us to target specific diseases and create disease-specific drugs.
			StaticText ​
			StaticText ​
			StaticText ​
			StaticText ​
			StaticText Our technology platform represents a convergence of microbial science, pharmaceutical innovation, and precision medicine, offering new hope for patients across multiple therapeutic areas.
		paragraph
			StaticText ​
		paragraph
			StaticText ​Join us on this exciting journey as we work towards a healthier future, one molecule at a time.
		image Picture8.png, url='https://static.wixstatic.com/media/abea01_9094b1a8a7244cb4ab172a819b6a0f35~mv2.png/v1/crop/x_0,y_31,w_289,h_147/fill/w_135,h_69,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture8.png'
		image Picture8.png, url='https://static.wixstatic.com/media/abea01_9094b1a8a7244cb4ab172a819b6a0f35~mv2.png/v1/crop/x_0,y_31,w_289,h_147/fill/w_135,h_69,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture8.png'
		image, url='https://static.wixstatic.com/media/11062b_abc71d59eb914d39963b8882c18e42acf000.jpg/v1/fill/w_1920,h_584,al_c,q_85,usm_0.33_1.00_0.00,enc_avif,quality_auto/11062b_abc71d59eb914d39963b8882c18e42acf000.jpg'
		heading INNOVATIVE  DRUGS
			StaticText INNOVATIVE  DRUGS
		heading PREDICTABLE OUTCOMES
			StaticText PREDICTABLE OUTCOMES
		heading Innovative Oral   Formulations Allow for Consistent Clinical Outcomes
			StaticText Innovative Oral   Formulations Allow for Consistent Clinical Outcomes
		heading PATHWAY TARGETED
			StaticText PATHWAY TARGETED
		heading Small Molecules that Interact Selectively with Disease-specific Targets and Maintain Immune Homeostasis
			StaticText Small Molecules that Interact Selectively with Disease-specific Targets and Maintain Immune Homeostasis
		heading SUPERIOR  SAFETY
			StaticText SUPERIOR
			StaticText SAFETY
		heading Small Molecules that Mimic Endogenous Substances found in the Human Body
			StaticText Small Molecules that Mimic Endogenous Substances found in the Human Body
		heading HIGHLY EFFICACIOUS
			StaticText HIGHLY EFFICACIOUS
		heading Boosts Anti-inlammatory IL-10 Expression and Downregulates Pro-inflammatory Cytokines
			StaticText Boosts Anti-inlammatory IL-10 Expression and Downregulates Pro-inflammatory Cytokines
		heading LOW COST
			StaticText LOW COST
		heading Seamless Manufacturing Process
			StaticText Seamless Manufacturing Process
		heading POWERFUL  and  NOVEL  PLATFORM
			StaticText POWERFUL  and  NOVEL  PLATFORM
		image 102158395_eps_normal_none [Converted].png, url='https://static.wixstatic.com/media/abea01_08ad758a19dd4b5f976a8010220e7a2d~mv2.png/v1/fill/w_477,h_570,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/102158395_eps_normal_none%20%5BConverted%5D.png'
		heading 1
			StaticText 1
		heading 2
			StaticText 2
		heading 3
			StaticText 3
		heading 4
			StaticText 4
		image Antibody Icon, url='https://static.wixstatic.com/media/abea01_84225a0b389f454f95b2849d41064cb0~mv2.png/v1/fill/w_45,h_45,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Antibody%20Icon.png'
		image Picture46_edited.png, url='https://static.wixstatic.com/media/abea01_896c0ee5b0aa4b1b8a06d33f57365fdd~mv2.png/v1/fill/w_37,h_40,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture46_edited.png'
		image Picture45.png, url='https://static.wixstatic.com/media/abea01_e6228c8859854d759643726a8b6a67bc~mv2.png/v1/fill/w_49,h_33,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture45.png'
		paragraph
			StaticText TARGETED BIOSYNTHESIS
		paragraph
			StaticText PLATFORM
		image, url='https://static.wixstatic.com/media/abea01_561ad84927e443eaa5ebec154e80781a~mv2.png/v1/fill/w_40,h_40,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/abea01_561ad84927e443eaa5ebec154e80781a~mv2.png'
		heading 5
			StaticText 5
		image Picture48.png, url='https://static.wixstatic.com/media/abea01_1c50e261858846ecad3e64c86149531f~mv2.png/v1/fill/w_40,h_39,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture48.png'
		paragraph
			StaticText AUTOIMMUNE DISEASES
		paragraph
			StaticText PSORIASIS, RHEUMATOID ARTHRITIS,
		paragraph
			StaticText UVEITIS AND BULLOUS PEMPHIGOID
		paragraph
			StaticText CANCERS
		paragraph
			StaticText HEPATOCELLULAR CARCINOMA, PANCREATIC CANCER AND MYELOID LEUKEMIAS
		paragraph
			StaticText INFECTIOUS DISEASES
		paragraph
			StaticText POST-VIRAL INFLAMMATORY COMPLICATIONS
			StaticText ​
		paragraph
			StaticText LIVER DISEASES
		paragraph
			StaticText FIBROSIS AND MASH/NASH
			StaticText ​
		paragraph
			StaticText ANTI-INFLAMMATORY
			StaticText ADJUVANTS
		paragraph
			StaticText CAR-T THERAPIES
		heading OUR PARTNERS
			StaticText OUR PARTNERS
		heading SFA THERAPEUTICS IS  A VENTURE  CAPITAL  BACKED  CLINICAL-STAGE  BIOTECHNOLOGY COMPANY
			StaticText SFA THERAPEUTICS
			StaticText IS  A
			StaticText VENTURE  CAPITAL
			StaticText BACKED  CLINICAL-STAGE  BIOTECHNOLOGY COMPANY
		image Asymmetry Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_e707b0deab604cba81a4fbdda7c82a32~mv2.png/v1/fill/w_117,h_91,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Asymmetry%20Ventures%20Logo.png'
		image North South Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_3ed5e8a47d9d4d2d9dcaa88292880d1f~mv2.png/v1/fill/w_63,h_6,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/North%20South%20Ventures%20Logo.png'
		image Acequia Capital Logo.png, url='https://static.wixstatic.com/media/abea01_bd9aaee4c8a9479c808cd749a436db26~mv2.png/v1/fill/w_63,h_8,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/Acequia%20Capital%20Logo.png'
		image Savantus Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_789593e55aec4012bc2f1c62a59326de~mv2.png/v1/crop/x_14,y_85,w_374,h_230/fill/w_132,h_81,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Savantus%20Ventures%20Logo.png'
		image Ben Franklin Logo.webp, url='https://static.wixstatic.com/media/abea01_7710334c8c7247ad82d0775c698b9e95~mv2.webp/v1/fill/w_134,h_54,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Ben%20Franklin%20Logo.webp'
		image Boost VC Logo.png, url='https://static.wixstatic.com/media/abea01_ae4cc4aac345493cb574810ebbe15b17~mv2.png/v1/fill/w_142,h_47,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Boost%20VC%20Logo.png'
		image INP Logo.png, url='https://static.wixstatic.com/media/abea01_43a99ccd82ec493b808647060e1aa4db~mv2.png/v1/fill/w_93,h_40,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/INP%20Logo.png'
		image ReInforced Ventures Logo.webp, url='https://static.wixstatic.com/media/abea01_49be6e8ade894940be2c40b8c4230457~mv2.webp/v1/fill/w_140,h_140,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/ReInforced%20Ventures%20Logo.webp'
		image Y Combinator.webp, url='https://static.wixstatic.com/media/abea01_b0d47c54798d49ddbf7914d050a85478~mv2.webp/v1/fill/w_194,h_97,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Y%20Combinator.webp'
		heading SFA  THERAPEUTICS  IN  THE  NEWS
			StaticText SFA
			StaticText THERAPEUTICS
			StaticText IN  THE  NEWS
		image 195420267_xl_normal_none.jpg, url='https://static.wixstatic.com/media/abea01_74592e1d61244c909fc26c4e5f22fae4~mv2.jpg/v1/fill/w_147,h_72,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/abea01_74592e1d61244c909fc26c4e5f22fae4~mv2.jpg'
		paragraph
			StaticText JENKINTOWN, Pa., May 17, 2024 BUSINESS WIRE --
			StaticText Article by SFA Therapeutics Founders Featured in Drug Target Review
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/the-promise-of-therapeutics-from-molecules-within-our-body'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., May 2, 2024 PRNewswire --
			StaticText SFA Therapeutics Strengthens Management Team with Appointment of Chief Medical Officer
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-strengthens-management-team-with-appointment-of-chief-medical-officer'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., February 29, 2024 BUSINESS WIRE --
			StaticText Ben Franklin Healthcare Investments: 1.3 Million in Four Companies
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/ben-franklin-healthcare-investments-invests-%241.3-million-in-four-companies'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., December 7, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics Announces Updated Psoriasis Data for SFA-002, Bridge Financing, and Foundational Patent
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-announces-updated-psoriasis-data-for-sfa-002%2C-bridge-financing%2C-and-foundational-patent'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., August 14, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics announces results for SFA-002 from Phase 1b Cohort 1 clinical trial for treatment of mild-to-moderate psoriasis
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-announces-results-for-sfa-002-from-phase-1b-cohort-1-clinical-trial-for-treatment-of-mild-to-moderate-psoriasis'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., August 14, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics Founders Publish an Article Titled “Short‑chain fatty acids in cancer pathogenesis”
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-founders-publish-an-article-titled-%E2%80%9Cshort%E2%80%91chain-fatty-acids-in-cancer-pathogenesis%E2%80%9D'
				StaticText READ MORE >>
		heading VISIT OUR ARCHIVES
			link VISIT OUR ARCHIVES, url='https://www.sfatherapeutics.com/news'
				StaticText VISIT OUR
				StaticText ARCHIVES
	contentinfo
		heading QUICK LINKS
			StaticText QUICK LINKS
		heading HOME
			link HOME, url='https://www.sfatherapeutics.com/'
				StaticText HOME
		image SFA Original Text Light, url='https://static.wixstatic.com/media/abea01_a9ae7b8182cc44c8a725294278f61e7f~mv2.png/v1/crop/x_0,y_33,w_590,h_134/fill/w_90,h_20,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/SFA%20Original%20Text%20Light.png'
		heading LOCATION
			StaticText LOCATION
		image Picture16.png, url='https://static.wixstatic.com/media/abea01_34572d42259d49b6a6f2697da2f4d2b3~mv2.png/v1/fill/w_109,h_102,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture16.png'
		paragraph
			StaticText 610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
		heading PSORIASIS
			link PSORIASIS, url='https://www.sfatherapeutics.com/clinical'
				StaticText PSORIASIS
		heading CAREERS
			link CAREERS, url='https://www.sfatherapeutics.com/general-1'
				StaticText CAREERS
		heading CONTACT FORM
			link CONTACT FORM, url='https://www.sfatherapeutics.com/contact'
				StaticText CONTACT FORM
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/company/sfa-therapeutics/'
		paragraph
			StaticText 267-584-1080
		paragraph
			link info@sfatherapeutics.com, url='mailto:info@sfatherapeutics.com'
		paragraph
			StaticText 2024 by SFA THERAPEUTICS, INC.
		paragraph
			StaticText All Rights Reserved.
	region bottom of page
```
</details>



```
RootWebArea HOME | Sfa Therapeutics 1, focused, url='https://www.sfatherapeutics.com/'
	region top of page
	button Skip to Main Content
	banner
		image Picture14.png, url='https://static.wixstatic.com/media/abea01_a79f1203843b4f1e869606561d1b7259~mv2.png/v1/crop/x_0,y_5,w_542,h_480/fill/w_99,h_88,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture14.png'
```
<details><summary>Show more</summary>

```
		image SFA Original Text.png, url='https://static.wixstatic.com/media/abea01_eddf156dbc904acf958c4ff6ba8dd10a~mv2.png/v1/crop/x_2,y_35,w_588,h_140/fill/w_332,h_79,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Original%20Text.png'
		heading TM
		navigation Site
			list
				listitem
					[115] link HOME, center=(520,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText HOME
				listitem
					[120] link ABOUT, center=(618,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText ABOUT
				listitem
					[125] link TEAM, center=(716,657), url='https://www.sfatherapeutics.com/team'
						paragraph
							StaticText TEAM
				listitem
					[130] link SCIENCE, center=(814,657), url='https://www.sfatherapeutics.com/science'
						paragraph
							StaticText SCIENCE
				listitem
					[135] link PLATFORM, center=(912,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText PLATFORM
				listitem
					[140] link PIPELINE, center=(1010,657), url='https://www.sfatherapeutics.com/pipeline'
						paragraph
							StaticText PIPELINE
				listitem
					[145] link CLINICAL, center=(1108,657), url='https://www.sfatherapeutics.com/clinical'
						paragraph
							StaticText CLINICAL
				listitem
					[150] link NEWS, center=(1206,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText NEWS
				listitem
					[158] link INVESTORS, center=(1304,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText INVESTORS
				listitem
					[163] link CONTACT, center=(1400,657), url='https://www.sfatherapeutics.com/contact'
						paragraph
							StaticText CONTACT
	main
		image, url='https://static.wixstatic.com/media/abea01_71c4bfa475cd4dca964663ebc6e5a564f000.jpg/v1/fill/w_1920,h_1080,al_c,q_90,usm_0.33_1.00_0.00,enc_avif,quality_auto/abea01_71c4bfa475cd4dca964663ebc6e5a564f000.jpg'
		heading NEXT  GENERATION  DRUGS  TO  TREAT AUTOIMMUNE,  CHRONIC   INFLAMMATORY   DISEASE AND  CANCER
			StaticText NEXT  GENERATION
			StaticText DRUGS  TO  TREAT
			StaticText AUTOIMMUNE,  CHRONIC   INFLAMMATORY   DISEASE
		generic ABOUT SFA THERAPEUTICS Our journey began with a deep fascination for the intricate world of the human gut bacterial ecosystem and its profound impact on overall well-being.  Our founders, a team of passionate researchers and healthcare professionals, were intrigued by the pivotal role this complex microbiota plays in maintaining human health.  The various bacteria produce a complex, yet synergistic, set of metabolites in our intestines that exhibit profound, wide-ranging effects on metabolism and immune function. ​​ ​​ ​​ ​As we delved deeper into the science, we uncovered the potential of these biosynthetic molecules, that mimic naturally occurring substances, in addressing a variety of health challenges, from autoimmune disease to metabolic disorders. We were particularly captivated by how these simple organic compounds could influence complex cellular processes and serve as a communication bridge between our gut microbiome and immune system. ​ ​​ ​​​​​ We discovered ways of increasing the selectivity and specifictiy of our biosynthetics after elucidating pathways and targets.  We have developed a platform technology that allows us to target specific diseases and create disease-specific drugs.  ​​​​Our technology platform represents a convergence of microbial science, pharmaceutical innovation, and precision medicine, offering new hope for patients across multiple therapeutic areas.   ​ ​Join us on this exciting journey as we work towards a healthier future, one molecule at a time. Picture8.png Picture8.png, focused
			heading ABOUT SFA THERAPEUTICS
				StaticText ABOUT SFA THERAPEUTICS
			paragraph
				StaticText Our journey began with a deep fascination for the intricate world of the human gut bacterial ecosystem and its profound impact on overall well-being.  Our founders, a team of passionate researchers and healthcare professionals, were intrigued by the pivotal role this complex microbiota plays in maintaining human health.  The various bacteria produce a complex, yet synergistic, set of metabolites in our intestines that exhibit profound, wide-ranging effects on metabolism and immune function.
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​As we delved deeper into the science, we uncovered the potential of these biosynthetic molecules, that mimic naturally occurring substances, in addressing a variety of health challenges, from autoimmune disease to metabolic disorders. We were particularly captivated by how these simple organic compounds could influence complex cellular processes and serve as a communication bridge between our gut microbiome and immune system.
			paragraph
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText ​
			paragraph
				StaticText We discovered ways of increasing the selectivity and specifictiy of our biosynthetics after elucidating pathways and targets.  We have developed a platform technology that allows us to target specific diseases and create disease-specific drugs.
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText Our technology platform represents a convergence of microbial science, pharmaceutical innovation, and precision medicine, offering new hope for patients across multiple therapeutic areas.
			paragraph
				StaticText ​
			paragraph
				StaticText ​Join us on this exciting journey as we work towards a healthier future, one molecule at a time.
			image Picture8.png, url='https://static.wixstatic.com/media/abea01_9094b1a8a7244cb4ab172a819b6a0f35~mv2.png/v1/crop/x_0,y_31,w_289,h_147/fill/w_135,h_69,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture8.png'
			image Picture8.png, url='https://static.wixstatic.com/media/abea01_9094b1a8a7244cb4ab172a819b6a0f35~mv2.png/v1/crop/x_0,y_31,w_289,h_147/fill/w_135,h_69,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture8.png'
		image, url='https://static.wixstatic.com/media/11062b_abc71d59eb914d39963b8882c18e42acf000.jpg/v1/fill/w_1920,h_584,al_c,q_85,usm_0.33_1.00_0.00,enc_avif,quality_auto/11062b_abc71d59eb914d39963b8882c18e42acf000.jpg'
		heading INNOVATIVE  DRUGS
			StaticText INNOVATIVE  DRUGS
		heading PREDICTABLE OUTCOMES
			StaticText PREDICTABLE OUTCOMES
		heading Innovative Oral   Formulations Allow for Consistent Clinical Outcomes
			StaticText Innovative Oral   Formulations Allow for Consistent Clinical Outcomes
		heading PATHWAY TARGETED
			StaticText PATHWAY TARGETED
		heading Small Molecules that Interact Selectively with Disease-specific Targets and Maintain Immune Homeostasis
			StaticText Small Molecules that Interact Selectively with Disease-specific Targets and Maintain Immune Homeostasis
		heading SUPERIOR  SAFETY
			StaticText SUPERIOR
			StaticText SAFETY
		heading Small Molecules that Mimic Endogenous Substances found in the Human Body
			StaticText Small Molecules that Mimic Endogenous Substances found in the Human Body
		heading HIGHLY EFFICACIOUS
			StaticText HIGHLY EFFICACIOUS
		heading Boosts Anti-inlammatory IL-10 Expression and Downregulates Pro-inflammatory Cytokines
			StaticText Boosts Anti-inlammatory IL-10 Expression and Downregulates Pro-inflammatory Cytokines
		heading LOW COST
			StaticText LOW COST
		heading Seamless Manufacturing Process
			StaticText Seamless Manufacturing Process
		heading POWERFUL  and  NOVEL  PLATFORM
			StaticText POWERFUL  and  NOVEL  PLATFORM
		image 102158395_eps_normal_none [Converted].png, url='https://static.wixstatic.com/media/abea01_08ad758a19dd4b5f976a8010220e7a2d~mv2.png/v1/fill/w_477,h_570,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/102158395_eps_normal_none%20%5BConverted%5D.png'
		heading 1
			StaticText 1
		heading 2
			StaticText 2
		heading 3
			StaticText 3
		heading 4
			StaticText 4
		image Antibody Icon, url='https://static.wixstatic.com/media/abea01_84225a0b389f454f95b2849d41064cb0~mv2.png/v1/fill/w_45,h_45,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Antibody%20Icon.png'
		image Picture46_edited.png, url='https://static.wixstatic.com/media/abea01_896c0ee5b0aa4b1b8a06d33f57365fdd~mv2.png/v1/fill/w_40,h_40,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture46_edited.png'
		image Picture45.png, url='https://static.wixstatic.com/media/abea01_e6228c8859854d759643726a8b6a67bc~mv2.png/v1/fill/w_53,h_33,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture45.png'
		paragraph
			StaticText TARGETED BIOSYNTHESIS
		paragraph
			StaticText PLATFORM
		image, url='https://static.wixstatic.com/media/abea01_561ad84927e443eaa5ebec154e80781a~mv2.png/v1/fill/w_40,h_40,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/abea01_561ad84927e443eaa5ebec154e80781a~mv2.png'
		heading 5
			StaticText 5
		image Picture48.png, url='https://static.wixstatic.com/media/abea01_1c50e261858846ecad3e64c86149531f~mv2.png/v1/fill/w_40,h_40,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture48.png'
		paragraph
			StaticText AUTOIMMUNE DISEASES
		paragraph
			StaticText PSORIASIS, RHEUMATOID ARTHRITIS,
		paragraph
			StaticText UVEITIS AND BULLOUS PEMPHIGOID
		paragraph
			StaticText CANCERS
		paragraph
			StaticText HEPATOCELLULAR CARCINOMA, PANCREATIC CANCER AND MYELOID LEUKEMIAS
		paragraph
			StaticText INFECTIOUS DISEASES
		paragraph
			StaticText POST-VIRAL INFLAMMATORY COMPLICATIONS
			StaticText ​
		paragraph
			StaticText LIVER DISEASES
		paragraph
			StaticText FIBROSIS AND MASH/NASH
			StaticText ​
		paragraph
			StaticText ANTI-INFLAMMATORY
			StaticText ADJUVANTS
		paragraph
			StaticText CAR-T THERAPIES
		heading OUR PARTNERS
			StaticText OUR PARTNERS
		heading SFA THERAPEUTICS IS  A VENTURE  CAPITAL  BACKED  CLINICAL-STAGE  BIOTECHNOLOGY COMPANY
			StaticText SFA THERAPEUTICS
			StaticText IS  A
			StaticText VENTURE  CAPITAL
			StaticText BACKED  CLINICAL-STAGE  BIOTECHNOLOGY COMPANY
		image Asymmetry Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_e707b0deab604cba81a4fbdda7c82a32~mv2.png/v1/fill/w_117,h_91,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Asymmetry%20Ventures%20Logo.png'
		image North South Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_3ed5e8a47d9d4d2d9dcaa88292880d1f~mv2.png/v1/fill/w_63,h_6,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/North%20South%20Ventures%20Logo.png'
		image Acequia Capital Logo.png, url='https://static.wixstatic.com/media/abea01_bd9aaee4c8a9479c808cd749a436db26~mv2.png/v1/fill/w_63,h_8,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/Acequia%20Capital%20Logo.png'
		image Savantus Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_789593e55aec4012bc2f1c62a59326de~mv2.png/v1/crop/x_14,y_85,w_374,h_230/fill/w_132,h_81,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Savantus%20Ventures%20Logo.png'
		image Ben Franklin Logo.webp, url='https://static.wixstatic.com/media/abea01_7710334c8c7247ad82d0775c698b9e95~mv2.webp/v1/fill/w_134,h_54,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Ben%20Franklin%20Logo.webp'
		image Boost VC Logo.png, url='https://static.wixstatic.com/media/abea01_ae4cc4aac345493cb574810ebbe15b17~mv2.png/v1/fill/w_142,h_47,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Boost%20VC%20Logo.png'
		image INP Logo.png, url='https://static.wixstatic.com/media/abea01_43a99ccd82ec493b808647060e1aa4db~mv2.png/v1/fill/w_93,h_40,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/INP%20Logo.png'
		image ReInforced Ventures Logo.webp, url='https://static.wixstatic.com/media/abea01_49be6e8ade894940be2c40b8c4230457~mv2.webp/v1/fill/w_140,h_140,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/ReInforced%20Ventures%20Logo.webp'
		image Y Combinator.webp, url='https://static.wixstatic.com/media/abea01_b0d47c54798d49ddbf7914d050a85478~mv2.webp/v1/fill/w_194,h_97,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Y%20Combinator.webp'
		heading SFA  THERAPEUTICS  IN  THE  NEWS
			StaticText SFA
			StaticText THERAPEUTICS
			StaticText IN  THE  NEWS
		image 195420267_xl_normal_none.jpg, url='https://static.wixstatic.com/media/abea01_74592e1d61244c909fc26c4e5f22fae4~mv2.jpg/v1/fill/w_147,h_72,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/abea01_74592e1d61244c909fc26c4e5f22fae4~mv2.jpg'
		paragraph
			StaticText JENKINTOWN, Pa., May 17, 2024 BUSINESS WIRE --
			StaticText Article by SFA Therapeutics Founders Featured in Drug Target Review
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/the-promise-of-therapeutics-from-molecules-within-our-body'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., May 2, 2024 PRNewswire --
			StaticText SFA Therapeutics Strengthens Management Team with Appointment of Chief Medical Officer
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-strengthens-management-team-with-appointment-of-chief-medical-officer'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., February 29, 2024 BUSINESS WIRE --
			StaticText Ben Franklin Healthcare Investments: 1.3 Million in Four Companies
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/ben-franklin-healthcare-investments-invests-%241.3-million-in-four-companies'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., December 7, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics Announces Updated Psoriasis Data for SFA-002, Bridge Financing, and Foundational Patent
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-announces-updated-psoriasis-data-for-sfa-002%2C-bridge-financing%2C-and-foundational-patent'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., August 14, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics announces results for SFA-002 from Phase 1b Cohort 1 clinical trial for treatment of mild-to-moderate psoriasis
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-announces-results-for-sfa-002-from-phase-1b-cohort-1-clinical-trial-for-treatment-of-mild-to-moderate-psoriasis'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., August 14, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics Founders Publish an Article Titled “Short‑chain fatty acids in cancer pathogenesis”
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-founders-publish-an-article-titled-%E2%80%9Cshort%E2%80%91chain-fatty-acids-in-cancer-pathogenesis%E2%80%9D'
				StaticText READ MORE >>
		heading VISIT OUR ARCHIVES
			link VISIT OUR ARCHIVES, url='https://www.sfatherapeutics.com/news'
				StaticText VISIT OUR
				StaticText ARCHIVES
	contentinfo
		heading QUICK LINKS
			StaticText QUICK LINKS
		heading HOME
			link HOME, url='https://www.sfatherapeutics.com/'
				StaticText HOME
		image SFA Original Text Light, url='https://static.wixstatic.com/media/abea01_a9ae7b8182cc44c8a725294278f61e7f~mv2.png/v1/crop/x_0,y_33,w_590,h_134/fill/w_90,h_20,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/SFA%20Original%20Text%20Light.png'
		heading LOCATION
			StaticText LOCATION
		image Picture16.png, url='https://static.wixstatic.com/media/abea01_34572d42259d49b6a6f2697da2f4d2b3~mv2.png/v1/fill/w_109,h_102,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture16.png'
		paragraph
			StaticText 610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
		heading PSORIASIS
			link PSORIASIS, url='https://www.sfatherapeutics.com/clinical'
				StaticText PSORIASIS
		heading CAREERS
			link CAREERS, url='https://www.sfatherapeutics.com/general-1'
				StaticText CAREERS
		heading CONTACT FORM
			link CONTACT FORM, url='https://www.sfatherapeutics.com/contact'
				StaticText CONTACT FORM
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/company/sfa-therapeutics/'
		paragraph
			StaticText 267-584-1080
		paragraph
			link info@sfatherapeutics.com, url='mailto:info@sfatherapeutics.com'
		paragraph
			StaticText 2024 by SFA THERAPEUTICS, INC.
		paragraph
			StaticText All Rights Reserved.
	region bottom of page
```
</details>

**Reasoning for action:** By clicking the ABOUT link, I am attempting to gather broader context and insights related to SFA Therapeutics, which will help me to understand their mission, vision, and the qualifications of their key personnel. This page might contain links or references regarding the team and major figures in the organization, including Dr. Ira Spector, allowing me to continue my goal of learning more about the key personnel.

**Action:** click(120) # Click on the ABOUT link to learn more about SFA Therapeutics.

**Change Description:** The browser navigated to the ABOUT page of SFA Therapeutics, displaying detailed information about the company and its journey in the research of microbiota and biosynthetic drugs, which replaces the previous content from the HOME page.

**Screenshot before:****Screenshot after:**---

**Step 2:**

**Url (before/after):** 

https://www.sfatherapeutics.com/

https://www.sfatherapeutics.com/team

**Content (before/after):** 

```
RootWebArea HOME | Sfa Therapeutics 1, focused, url='https://www.sfatherapeutics.com/'
	region top of page
	button Skip to Main Content
	banner
		image Picture14.png, url='https://static.wixstatic.com/media/abea01_a79f1203843b4f1e869606561d1b7259~mv2.png/v1/crop/x_0,y_5,w_542,h_480/fill/w_99,h_88,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture14.png'
```
<details><summary>Show more</summary>

```
		image SFA Original Text.png, url='https://static.wixstatic.com/media/abea01_eddf156dbc904acf958c4ff6ba8dd10a~mv2.png/v1/crop/x_2,y_35,w_588,h_140/fill/w_332,h_79,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Original%20Text.png'
		heading TM
		navigation Site
			list
				listitem
					[115] link HOME, center=(520,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText HOME
				listitem
					[120] link ABOUT, center=(618,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText ABOUT
				listitem
					[125] link TEAM, center=(716,657), url='https://www.sfatherapeutics.com/team'
						paragraph
							StaticText TEAM
				listitem
					[130] link SCIENCE, center=(814,657), url='https://www.sfatherapeutics.com/science'
						paragraph
							StaticText SCIENCE
				listitem
					[135] link PLATFORM, center=(912,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText PLATFORM
				listitem
					[140] link PIPELINE, center=(1010,657), url='https://www.sfatherapeutics.com/pipeline'
						paragraph
							StaticText PIPELINE
				listitem
					[145] link CLINICAL, center=(1108,657), url='https://www.sfatherapeutics.com/clinical'
						paragraph
							StaticText CLINICAL
				listitem
					[150] link NEWS, center=(1206,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText NEWS
				listitem
					[158] link INVESTORS, center=(1304,657), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText INVESTORS
				listitem
					[163] link CONTACT, center=(1400,657), url='https://www.sfatherapeutics.com/contact'
						paragraph
							StaticText CONTACT
	main
		image, url='https://static.wixstatic.com/media/abea01_71c4bfa475cd4dca964663ebc6e5a564f000.jpg/v1/fill/w_1920,h_1080,al_c,q_90,usm_0.33_1.00_0.00,enc_avif,quality_auto/abea01_71c4bfa475cd4dca964663ebc6e5a564f000.jpg'
		heading NEXT  GENERATION  DRUGS  TO  TREAT AUTOIMMUNE,  CHRONIC   INFLAMMATORY   DISEASE AND  CANCER
			StaticText NEXT  GENERATION
			StaticText DRUGS  TO  TREAT
			StaticText AUTOIMMUNE,  CHRONIC   INFLAMMATORY   DISEASE
		generic ABOUT SFA THERAPEUTICS Our journey began with a deep fascination for the intricate world of the human gut bacterial ecosystem and its profound impact on overall well-being.  Our founders, a team of passionate researchers and healthcare professionals, were intrigued by the pivotal role this complex microbiota plays in maintaining human health.  The various bacteria produce a complex, yet synergistic, set of metabolites in our intestines that exhibit profound, wide-ranging effects on metabolism and immune function. ​​ ​​ ​​ ​As we delved deeper into the science, we uncovered the potential of these biosynthetic molecules, that mimic naturally occurring substances, in addressing a variety of health challenges, from autoimmune disease to metabolic disorders. We were particularly captivated by how these simple organic compounds could influence complex cellular processes and serve as a communication bridge between our gut microbiome and immune system. ​ ​​ ​​​​​ We discovered ways of increasing the selectivity and specifictiy of our biosynthetics after elucidating pathways and targets.  We have developed a platform technology that allows us to target specific diseases and create disease-specific drugs.  ​​​​Our technology platform represents a convergence of microbial science, pharmaceutical innovation, and precision medicine, offering new hope for patients across multiple therapeutic areas.   ​ ​Join us on this exciting journey as we work towards a healthier future, one molecule at a time. Picture8.png Picture8.png, focused
			heading ABOUT SFA THERAPEUTICS
				StaticText ABOUT SFA THERAPEUTICS
			paragraph
				StaticText Our journey began with a deep fascination for the intricate world of the human gut bacterial ecosystem and its profound impact on overall well-being.  Our founders, a team of passionate researchers and healthcare professionals, were intrigued by the pivotal role this complex microbiota plays in maintaining human health.  The various bacteria produce a complex, yet synergistic, set of metabolites in our intestines that exhibit profound, wide-ranging effects on metabolism and immune function.
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​As we delved deeper into the science, we uncovered the potential of these biosynthetic molecules, that mimic naturally occurring substances, in addressing a variety of health challenges, from autoimmune disease to metabolic disorders. We were particularly captivated by how these simple organic compounds could influence complex cellular processes and serve as a communication bridge between our gut microbiome and immune system.
			paragraph
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
			paragraph
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText ​
			paragraph
				StaticText We discovered ways of increasing the selectivity and specifictiy of our biosynthetics after elucidating pathways and targets.  We have developed a platform technology that allows us to target specific diseases and create disease-specific drugs.
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText ​
				StaticText Our technology platform represents a convergence of microbial science, pharmaceutical innovation, and precision medicine, offering new hope for patients across multiple therapeutic areas.
			paragraph
				StaticText ​
			paragraph
				StaticText ​Join us on this exciting journey as we work towards a healthier future, one molecule at a time.
			image Picture8.png, url='https://static.wixstatic.com/media/abea01_9094b1a8a7244cb4ab172a819b6a0f35~mv2.png/v1/crop/x_0,y_31,w_289,h_147/fill/w_135,h_69,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture8.png'
			image Picture8.png, url='https://static.wixstatic.com/media/abea01_9094b1a8a7244cb4ab172a819b6a0f35~mv2.png/v1/crop/x_0,y_31,w_289,h_147/fill/w_135,h_69,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture8.png'
		image, url='https://static.wixstatic.com/media/11062b_abc71d59eb914d39963b8882c18e42acf000.jpg/v1/fill/w_1920,h_584,al_c,q_85,usm_0.33_1.00_0.00,enc_avif,quality_auto/11062b_abc71d59eb914d39963b8882c18e42acf000.jpg'
		heading INNOVATIVE  DRUGS
			StaticText INNOVATIVE  DRUGS
		heading PREDICTABLE OUTCOMES
			StaticText PREDICTABLE OUTCOMES
		heading Innovative Oral   Formulations Allow for Consistent Clinical Outcomes
			StaticText Innovative Oral   Formulations Allow for Consistent Clinical Outcomes
		heading PATHWAY TARGETED
			StaticText PATHWAY TARGETED
		heading Small Molecules that Interact Selectively with Disease-specific Targets and Maintain Immune Homeostasis
			StaticText Small Molecules that Interact Selectively with Disease-specific Targets and Maintain Immune Homeostasis
		heading SUPERIOR  SAFETY
			StaticText SUPERIOR
			StaticText SAFETY
		heading Small Molecules that Mimic Endogenous Substances found in the Human Body
			StaticText Small Molecules that Mimic Endogenous Substances found in the Human Body
		heading HIGHLY EFFICACIOUS
			StaticText HIGHLY EFFICACIOUS
		heading Boosts Anti-inlammatory IL-10 Expression and Downregulates Pro-inflammatory Cytokines
			StaticText Boosts Anti-inlammatory IL-10 Expression and Downregulates Pro-inflammatory Cytokines
		heading LOW COST
			StaticText LOW COST
		heading Seamless Manufacturing Process
			StaticText Seamless Manufacturing Process
		heading POWERFUL  and  NOVEL  PLATFORM
			StaticText POWERFUL  and  NOVEL  PLATFORM
		image 102158395_eps_normal_none [Converted].png, url='https://static.wixstatic.com/media/abea01_08ad758a19dd4b5f976a8010220e7a2d~mv2.png/v1/fill/w_477,h_570,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/102158395_eps_normal_none%20%5BConverted%5D.png'
		heading 1
			StaticText 1
		heading 2
			StaticText 2
		heading 3
			StaticText 3
		heading 4
			StaticText 4
		image Antibody Icon, url='https://static.wixstatic.com/media/abea01_84225a0b389f454f95b2849d41064cb0~mv2.png/v1/fill/w_45,h_45,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Antibody%20Icon.png'
		image Picture46_edited.png, url='https://static.wixstatic.com/media/abea01_896c0ee5b0aa4b1b8a06d33f57365fdd~mv2.png/v1/fill/w_40,h_40,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture46_edited.png'
		image Picture45.png, url='https://static.wixstatic.com/media/abea01_e6228c8859854d759643726a8b6a67bc~mv2.png/v1/fill/w_53,h_33,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture45.png'
		paragraph
			StaticText TARGETED BIOSYNTHESIS
		paragraph
			StaticText PLATFORM
		image, url='https://static.wixstatic.com/media/abea01_561ad84927e443eaa5ebec154e80781a~mv2.png/v1/fill/w_40,h_40,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/abea01_561ad84927e443eaa5ebec154e80781a~mv2.png'
		heading 5
			StaticText 5
		image Picture48.png, url='https://static.wixstatic.com/media/abea01_1c50e261858846ecad3e64c86149531f~mv2.png/v1/fill/w_40,h_40,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture48.png'
		paragraph
			StaticText AUTOIMMUNE DISEASES
		paragraph
			StaticText PSORIASIS, RHEUMATOID ARTHRITIS,
		paragraph
			StaticText UVEITIS AND BULLOUS PEMPHIGOID
		paragraph
			StaticText CANCERS
		paragraph
			StaticText HEPATOCELLULAR CARCINOMA, PANCREATIC CANCER AND MYELOID LEUKEMIAS
		paragraph
			StaticText INFECTIOUS DISEASES
		paragraph
			StaticText POST-VIRAL INFLAMMATORY COMPLICATIONS
			StaticText ​
		paragraph
			StaticText LIVER DISEASES
		paragraph
			StaticText FIBROSIS AND MASH/NASH
			StaticText ​
		paragraph
			StaticText ANTI-INFLAMMATORY
			StaticText ADJUVANTS
		paragraph
			StaticText CAR-T THERAPIES
		heading OUR PARTNERS
			StaticText OUR PARTNERS
		heading SFA THERAPEUTICS IS  A VENTURE  CAPITAL  BACKED  CLINICAL-STAGE  BIOTECHNOLOGY COMPANY
			StaticText SFA THERAPEUTICS
			StaticText IS  A
			StaticText VENTURE  CAPITAL
			StaticText BACKED  CLINICAL-STAGE  BIOTECHNOLOGY COMPANY
		image Asymmetry Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_e707b0deab604cba81a4fbdda7c82a32~mv2.png/v1/fill/w_117,h_91,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Asymmetry%20Ventures%20Logo.png'
		image North South Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_3ed5e8a47d9d4d2d9dcaa88292880d1f~mv2.png/v1/fill/w_63,h_6,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/North%20South%20Ventures%20Logo.png'
		image Acequia Capital Logo.png, url='https://static.wixstatic.com/media/abea01_bd9aaee4c8a9479c808cd749a436db26~mv2.png/v1/fill/w_63,h_8,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/Acequia%20Capital%20Logo.png'
		image Savantus Ventures Logo.png, url='https://static.wixstatic.com/media/abea01_789593e55aec4012bc2f1c62a59326de~mv2.png/v1/crop/x_14,y_85,w_374,h_230/fill/w_132,h_81,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Savantus%20Ventures%20Logo.png'
		image Ben Franklin Logo.webp, url='https://static.wixstatic.com/media/abea01_7710334c8c7247ad82d0775c698b9e95~mv2.webp/v1/fill/w_134,h_54,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Ben%20Franklin%20Logo.webp'
		image Boost VC Logo.png, url='https://static.wixstatic.com/media/abea01_ae4cc4aac345493cb574810ebbe15b17~mv2.png/v1/fill/w_142,h_47,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Boost%20VC%20Logo.png'
		image INP Logo.png, url='https://static.wixstatic.com/media/abea01_43a99ccd82ec493b808647060e1aa4db~mv2.png/v1/fill/w_93,h_40,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/INP%20Logo.png'
		image ReInforced Ventures Logo.webp, url='https://static.wixstatic.com/media/abea01_49be6e8ade894940be2c40b8c4230457~mv2.webp/v1/fill/w_140,h_140,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/ReInforced%20Ventures%20Logo.webp'
		image Y Combinator.webp, url='https://static.wixstatic.com/media/abea01_b0d47c54798d49ddbf7914d050a85478~mv2.webp/v1/fill/w_194,h_97,al_c,q_80,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Y%20Combinator.webp'
		heading SFA  THERAPEUTICS  IN  THE  NEWS
			StaticText SFA
			StaticText THERAPEUTICS
			StaticText IN  THE  NEWS
		image 195420267_xl_normal_none.jpg, url='https://static.wixstatic.com/media/abea01_74592e1d61244c909fc26c4e5f22fae4~mv2.jpg/v1/fill/w_147,h_72,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/abea01_74592e1d61244c909fc26c4e5f22fae4~mv2.jpg'
		paragraph
			StaticText JENKINTOWN, Pa., May 17, 2024 BUSINESS WIRE --
			StaticText Article by SFA Therapeutics Founders Featured in Drug Target Review
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/the-promise-of-therapeutics-from-molecules-within-our-body'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., May 2, 2024 PRNewswire --
			StaticText SFA Therapeutics Strengthens Management Team with Appointment of Chief Medical Officer
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-strengthens-management-team-with-appointment-of-chief-medical-officer'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., February 29, 2024 BUSINESS WIRE --
			StaticText Ben Franklin Healthcare Investments: 1.3 Million in Four Companies
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/ben-franklin-healthcare-investments-invests-%241.3-million-in-four-companies'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., December 7, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics Announces Updated Psoriasis Data for SFA-002, Bridge Financing, and Foundational Patent
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-announces-updated-psoriasis-data-for-sfa-002%2C-bridge-financing%2C-and-foundational-patent'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., August 14, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics announces results for SFA-002 from Phase 1b Cohort 1 clinical trial for treatment of mild-to-moderate psoriasis
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-announces-results-for-sfa-002-from-phase-1b-cohort-1-clinical-trial-for-treatment-of-mild-to-moderate-psoriasis'
				StaticText READ MORE >>
		paragraph
			StaticText JENKINTOWN, Pa., August 14, 2023 BUSINESS WIRE --
			StaticText SFA Therapeutics Founders Publish an Article Titled “Short‑chain fatty acids in cancer pathogenesis”
		paragraph
			link READ MORE >>, url='https://www.sfatherapeutics.com/news/sfa-therapeutics-founders-publish-an-article-titled-%E2%80%9Cshort%E2%80%91chain-fatty-acids-in-cancer-pathogenesis%E2%80%9D'
				StaticText READ MORE >>
		heading VISIT OUR ARCHIVES
			link VISIT OUR ARCHIVES, url='https://www.sfatherapeutics.com/news'
				StaticText VISIT OUR
				StaticText ARCHIVES
	contentinfo
		heading QUICK LINKS
			StaticText QUICK LINKS
		heading HOME
			link HOME, url='https://www.sfatherapeutics.com/'
				StaticText HOME
		image SFA Original Text Light, url='https://static.wixstatic.com/media/abea01_a9ae7b8182cc44c8a725294278f61e7f~mv2.png/v1/crop/x_0,y_33,w_590,h_134/fill/w_90,h_20,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/SFA%20Original%20Text%20Light.png'
		heading LOCATION
			StaticText LOCATION
		image Picture16.png, url='https://static.wixstatic.com/media/abea01_34572d42259d49b6a6f2697da2f4d2b3~mv2.png/v1/fill/w_109,h_102,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture16.png'
		paragraph
			StaticText 610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
		heading PSORIASIS
			link PSORIASIS, url='https://www.sfatherapeutics.com/clinical'
				StaticText PSORIASIS
		heading CAREERS
			link CAREERS, url='https://www.sfatherapeutics.com/general-1'
				StaticText CAREERS
		heading CONTACT FORM
			link CONTACT FORM, url='https://www.sfatherapeutics.com/contact'
				StaticText CONTACT FORM
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/company/sfa-therapeutics/'
		paragraph
			StaticText 267-584-1080
		paragraph
			link info@sfatherapeutics.com, url='mailto:info@sfatherapeutics.com'
		paragraph
			StaticText 2024 by SFA THERAPEUTICS, INC.
		paragraph
			StaticText All Rights Reserved.
	region bottom of page
```
</details>



```
RootWebArea TEAM | Sfa Therapeutics 1, focused, url='https://www.sfatherapeutics.com/team'
	region top of page, focused
	button Skip to Main Content
	banner
		image Picture14.png, url='https://static.wixstatic.com/media/abea01_a79f1203843b4f1e869606561d1b7259~mv2.png/v1/crop/x_0,y_5,w_542,h_480/fill/w_99,h_88,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture14.png'
```
<details><summary>Show more</summary>

```
		image SFA Original Text.png, url='https://static.wixstatic.com/media/abea01_eddf156dbc904acf958c4ff6ba8dd10a~mv2.png/v1/crop/x_2,y_35,w_588,h_140/fill/w_332,h_79,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Original%20Text.png'
		heading TM
		navigation Site
			list
				listitem
					[115] link HOME, center=(520,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText HOME
				listitem
					[120] link ABOUT, center=(618,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText ABOUT
				listitem
					[125] link TEAM, center=(716,144), url='https://www.sfatherapeutics.com/team'
						paragraph
							StaticText TEAM
				listitem
					[130] link SCIENCE, center=(814,144), url='https://www.sfatherapeutics.com/science'
						paragraph
							StaticText SCIENCE
				listitem
					[135] link PLATFORM, center=(912,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText PLATFORM
				listitem
					[140] link PIPELINE, center=(1010,144), url='https://www.sfatherapeutics.com/pipeline'
						paragraph
							StaticText PIPELINE
				listitem
					[145] link CLINICAL, center=(1108,144), url='https://www.sfatherapeutics.com/clinical'
						paragraph
							StaticText CLINICAL
				listitem
					[150] link NEWS, center=(1206,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText NEWS
				listitem
					[158] link INVESTORS, center=(1304,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText INVESTORS
				listitem
					[163] link CONTACT, center=(1400,144), url='https://www.sfatherapeutics.com/contact'
						paragraph
							StaticText CONTACT
	main
		image Board Room v3.jpg, url='https://static.wixstatic.com/media/abea01_d4d308d951084370b2af9b7560397628~mv2.jpg/v1/fill/w_1920,h_1080,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/abea01_d4d308d951084370b2af9b7560397628~mv2.jpg'
		heading SFA THERAPEUTICS
			StaticText SFA
			StaticText THERAPEUTICS
		heading MEET  THE  TEAM
			StaticText MEET  THE
			StaticText TEAM
		heading MANAGEMENT AND FOUNDERS
			StaticText MANAGEMENT AND FOUNDERS
		[873] link Ira Spetor, center=(658,951), url='https://www.sfatherapeutics.com/ira-spector'
			image Ira Spetor, url='https://static.wixstatic.com/media/abea01_5b2d0096af4c4375a7f4e71a8ffcf769~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Ira%20Spetor.jpg'
		heading IRA C. SPECTOR - PhD CEO, CO-FOUNDER
			link IRA C. SPECTOR - PhD CEO, CO-FOUNDER, url='https://www.sfatherapeutics.com/ira-spector'
				StaticText IRA C. SPECTOR
				StaticText -
				StaticText PhD
				StaticText CEO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/ira-spector-00414310/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link James Kirwin_edited_edited.jpg, url='https://www.sfatherapeutics.com/james-kirwin'
			image James Kirwin_edited_edited.jpg, url='https://static.wixstatic.com/media/abea01_999a95a454bb411db9cdcc7309fae2f3~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/James%20Kirwin_edited_edited.jpg'
		heading JAMES KIRWIN -MBA COO, CO-FOUNDER
			link JAMES KIRWIN -MBA COO, CO-FOUNDER, url='https://www.sfatherapeutics.com/james-kirwin'
				StaticText JAMES KIRWIN -MBA
				StaticText COO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/james-kirwin-79482914/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Steve King.jpg, url='https://www.sfatherapeutics.com/steve-king'
			image Steve King.jpg, url='https://static.wixstatic.com/media/abea01_9dbaa39d3eb54f738d9a299c81adfe3f~mv2.jpg/v1/crop/x_68,y_0,w_370,h_540/fill/w_187,h_273,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Steve%20King.jpg'
		heading STEVE KING HEAD OF CMC
			link STEVE KING HEAD OF CMC, url='https://www.sfatherapeutics.com/robert-dickey'
				StaticText STEVE KING
				StaticText HEAD OF CMC
		list Social Bar
			listitem
				link https://www.linkedin.com/in/steve-king-6534aa5/, url='https://www.linkedin.com/in/robdickey/'
					image https://www.linkedin.com/in/steve-king-6534aa5/, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		[936] link Mark Feitelson, center=(960,951), url='https://www.sfatherapeutics.com/mark-feitelson'
			image Mark Feitelson, url='https://static.wixstatic.com/media/abea01_c7ad8e0ce41b4ff5bf4b49e18a6614ba~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Mark%20Feitelson.jpg'
		heading MARK FEITELSON - PhD CSO, CO-FOUNDER
			link MARK FEITELSON - PhD CSO, CO-FOUNDER, url='https://www.sfatherapeutics.com/mark-feitelson'
				StaticText MARK FEITELSON - PhD
				StaticText CSO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/mark-feitelson-707771a/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link King Lee, url='https://www.sfatherapeutics.com/king-lee'
			image King Lee, url='https://static.wixstatic.com/media/abea01_824bb01538ce41048932315adf65cd41~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/King%20Lee.jpg'
		heading KING LEE - PhD HEAD OF REGULATORY AFFAIRS
			link KING LEE - PhD, url='https://www.sfatherapeutics.com/james-kirwin'
				StaticText KING LEE - PhD
			link HEAD OF REGULATORY AFFAIRS, url='https://www.sfatherapeutics.com/james-kirwin'
				StaticText HEAD OF REGULATORY AFFAIRS
		list Social Bar
			listitem
				link https://www.linkedin.com/in/king-lee-2541317/, url='https://www.linkedin.com/in/king-lee-2541317/'
					image https://www.linkedin.com/in/king-lee-2541317/, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Robert Dickey_edited.jpg, url='https://www.sfatherapeutics.com/robert-dickey'
			image Robert Dickey_edited.jpg, url='https://static.wixstatic.com/media/abea01_cc009c709f224bf89dfc09d7d168eeb2~mv2.jpg/v1/crop/x_95,y_0,w_1065,h_1600/fill/w_183,h_275,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Robert%20Dickey_edited.jpg'
		heading ROBERT DICKEY - BA MBA CFO
			link ROBERT DICKEY - BA MBA CFO, url='https://www.sfatherapeutics.com/robert-dickey'
				StaticText ROBERT DICKEY - BA MBA
				StaticText CFO
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/robdickey/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		[1004] link IMG_6520_edited.jpg, center=(1264,951), url='https://www.sfatherapeutics.com/alla-arzumanyan'
			image IMG_6520_edited.jpg, url='https://static.wixstatic.com/media/abea01_a6fc3f2598dd499ca2821e1f26da54f7~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6520_edited.jpg'
		heading ALLA ARZUMANYAN - PhD  CDO, CO-FOUNDER
			link ALLA ARZUMANYAN - PhD  CDO, CO-FOUNDER, url='https://www.sfatherapeutics.com/alla-arzumanyan'
				StaticText ALLA ARZUMANYAN - PhD
				StaticText CDO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/alla-arzumanyan-66a79a18b/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Shawn O'Brien, url='https://www.sfatherapeutics.com/shawn-o-brien'
			image Shawn O'Brien, url="https://static.wixstatic.com/media/abea01_4f8ffc22876a465caaf810f15eaa97b1~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Shawn%20O'Brien.jpg"
		heading SHAWN O'BRIEN - MS MBA CHAIRMAN
			link SHAWN O'BRIEN - MS MBA CHAIRMAN, url='https://www.sfatherapeutics.com/shawn-o-brien'
				StaticText SHAWN O'BRIEN - MS MBA
				StaticText CHAIRMAN
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/shawn-patrick-o-brien/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Stefan Weiss, url='https://www.sfatherapeutics.com/stefan-weiss'
			image Stefan Weiss, url='https://static.wixstatic.com/media/abea01_fca81b48d7534b5bb2a2ea4c66ec9d50~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Stefan%20Weiss.jpg'
		heading STEFAN WEISS - MD CMO
			link STEFAN WEISS - MD CMO, url='https://www.sfatherapeutics.com/stefan-weiss'
				StaticText STEFAN WEISS - MD
				StaticText CMO
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/stefancweiss/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		heading SCIENTIFIC ADVISORY BOARD WITH RECOGNIZED KEY OPINION LEADERS
			StaticText SCIENTIFIC ADVISORY BOARD WITH
			StaticText RECOGNIZED KEY OPINION LEADERS
		image IMG_6297_edited.jpg, url='https://static.wixstatic.com/media/abea01_0604d9cb719a4cf195301f878b5b69c4~mv2.jpg/v1/fill/w_140,h_212,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6297_edited.jpg'
		heading SYLVIA HSU - MD DERMATOLOGY
			StaticText SYLVIA HSU - MD
			StaticText DERMATOLOGY
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/sylvia-hsu-9402a436/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		image IMG_6303.JPG, url='https://static.wixstatic.com/media/abea01_c7656f9a106a4238a3a98f9a91cc66d1~mv2.jpg/v1/fill/w_140,h_212,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6303_JPG.jpg'
		image IMG_6306_edited.jpg, url='https://static.wixstatic.com/media/abea01_4e2004b4d3ce404fbf659d033f641173~mv2.jpg/v1/fill/w_140,h_212,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6306_edited.jpg'
		image IMG_6350.JPG, url='https://static.wixstatic.com/media/abea01_a227d1caf6854c91a49b5a16edf2dcd7~mv2.jpg/v1/fill/w_141,h_214,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6350_JPG.jpg'
		image SAUDER_edited.jpg, url='https://static.wixstatic.com/media/abea01_10288e3e34c54c22a982a1aef2e44375~mv2.jpg/v1/fill/w_141,h_214,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/SAUDER_edited.jpg'
		heading CHRIS GALLEN - MD PhD IMMUNOLOGY
			StaticText CHRIS GALLEN - MD PhD
			StaticText IMMUNOLOGY
		heading BRENT KORBA - PhD VIROLOGY & IMMUNOLOGY
			StaticText BRENT KORBA - PhD
		heading JOSEPH CAMARDO - MD INDEPENDENT MEDICAL
			StaticText JOSEPH CAMARDO - MD
			StaticText INDEPENDENT MEDICAL
		heading DANIEL N. SAUDER - MD, FRCPC, FACP DERMATOLOGY
			StaticText DANIEL N. SAUDER -
			StaticText MD, FRCPC, FACP
			StaticText DERMATOLOGY
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/christopher-gallen-919b48/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/brent-korba-462424126/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/joe-camardo-3540aa15/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/daniel-sauder-8ba66835/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		heading BUSINESS ADVISORY TEAM
			StaticText BUSINESS ADVISORY TEAM
		paragraph
			StaticText CRAIG KENESKY - PhD IP COUNSEL
		paragraph
		paragraph
			StaticText IP Counsel, Wilson-Sonsini-Goodrich-Rosati
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/craig-kenesky-ph-d-1ab03a6/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText JORDAN WARSHAFSKY - MBA
		paragraph
			StaticText ​
		paragraph
			StaticText Business/HR Advisor,Ashton Tweed
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/jordan-warshafsky/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText ANDREW GILBERT - JD
		paragraph
			StaticText ​
		paragraph
			StaticText Corporate Counsel, DLA Piper
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/andrew-gilbert-2a11a31/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText KATE HERMANS - MASTER OF INTL MGMT
		paragraph
			StaticText ​
		paragraph
			StaticText Business / Commercial Strategy Advisor
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/katehermans/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText Ananda Gubbi - PhD
		paragraph
		paragraph
			StaticText Director of Biostatistics
		paragraph
			StaticText ANGELA LYNCH - PhD
		paragraph
			StaticText ​
		paragraph
			StaticText Pre-Clinical Development
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/betty-jean-swartz/'
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/angelalynchphdtoxplus/'
	contentinfo
		heading QUICK LINKS
			StaticText QUICK LINKS
		heading HOME
			link HOME, url='https://www.sfatherapeutics.com/'
				StaticText HOME
		image SFA Original Text Light, url='https://static.wixstatic.com/media/abea01_a9ae7b8182cc44c8a725294278f61e7f~mv2.png/v1/crop/x_0,y_33,w_590,h_134/fill/w_90,h_20,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/SFA%20Original%20Text%20Light.png'
		heading LOCATION
			StaticText LOCATION
		image Picture16.png, url='https://static.wixstatic.com/media/abea01_34572d42259d49b6a6f2697da2f4d2b3~mv2.png/v1/fill/w_109,h_102,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture16.png'
		paragraph
			StaticText 610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
		heading PSORIASIS
			link PSORIASIS, url='https://www.sfatherapeutics.com/clinical'
				StaticText PSORIASIS
		heading CAREERS
			link CAREERS, url='https://www.sfatherapeutics.com/general-1'
				StaticText CAREERS
		heading CONTACT FORM
			link CONTACT FORM, url='https://www.sfatherapeutics.com/contact'
				StaticText CONTACT FORM
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/company/sfa-therapeutics/'
		paragraph
			StaticText 267-584-1080
		paragraph
			link info@sfatherapeutics.com, url='mailto:info@sfatherapeutics.com'
		paragraph
			StaticText 2024 by SFA THERAPEUTICS, INC.
		paragraph
			StaticText All Rights Reserved.
	region bottom of page
```
</details>

**Reasoning for action:** By clicking on the TEAM link, I am accessing a section of the website specifically designed to present details about the key personnel at SFA Therapeutics. This is the first necessary step to fulfill the user story, as it leads me closer to finding the profile of Dr. Ira Spector, the CEO and co-founder, which will contain the detailed information needed for the user to assess the qualifications and expertise of the team.

**Action:** click(125) # Click on the TEAM link to learn more about the people behind SFA Therapeutics.

**Change Description:** After clicking the TEAM link, the browser state transitioned to the TEAM page of Sfa Therapeutics, where the main focus area now includes images and biographies of key personnel, replacing the previous home page content with information specifically about the organization's management and founders.

**Screenshot before:****Screenshot after:**---

**Step 3:**

**Url (before/after):** 

https://www.sfatherapeutics.com/team

https://www.sfatherapeutics.com/ira-spector

**Content (before/after):** 

```
RootWebArea TEAM | Sfa Therapeutics 1, focused, url='https://www.sfatherapeutics.com/team'
	region top of page, focused
	button Skip to Main Content
	banner
		image Picture14.png, url='https://static.wixstatic.com/media/abea01_a79f1203843b4f1e869606561d1b7259~mv2.png/v1/crop/x_0,y_5,w_542,h_480/fill/w_99,h_88,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture14.png'
```
<details><summary>Show more</summary>

```
		image SFA Original Text.png, url='https://static.wixstatic.com/media/abea01_eddf156dbc904acf958c4ff6ba8dd10a~mv2.png/v1/crop/x_2,y_35,w_588,h_140/fill/w_332,h_79,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Original%20Text.png'
		heading TM
		navigation Site
			list
				listitem
					[115] link HOME, center=(520,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText HOME
				listitem
					[120] link ABOUT, center=(618,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText ABOUT
				listitem
					[125] link TEAM, center=(716,144), url='https://www.sfatherapeutics.com/team'
						paragraph
							StaticText TEAM
				listitem
					[130] link SCIENCE, center=(814,144), url='https://www.sfatherapeutics.com/science'
						paragraph
							StaticText SCIENCE
				listitem
					[135] link PLATFORM, center=(912,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText PLATFORM
				listitem
					[140] link PIPELINE, center=(1010,144), url='https://www.sfatherapeutics.com/pipeline'
						paragraph
							StaticText PIPELINE
				listitem
					[145] link CLINICAL, center=(1108,144), url='https://www.sfatherapeutics.com/clinical'
						paragraph
							StaticText CLINICAL
				listitem
					[150] link NEWS, center=(1206,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText NEWS
				listitem
					[158] link INVESTORS, center=(1304,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText INVESTORS
				listitem
					[163] link CONTACT, center=(1400,144), url='https://www.sfatherapeutics.com/contact'
						paragraph
							StaticText CONTACT
	main
		image Board Room v3.jpg, url='https://static.wixstatic.com/media/abea01_d4d308d951084370b2af9b7560397628~mv2.jpg/v1/fill/w_1920,h_1080,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/abea01_d4d308d951084370b2af9b7560397628~mv2.jpg'
		heading SFA THERAPEUTICS
			StaticText SFA
			StaticText THERAPEUTICS
		heading MEET  THE  TEAM
			StaticText MEET  THE
			StaticText TEAM
		heading MANAGEMENT AND FOUNDERS
			StaticText MANAGEMENT AND FOUNDERS
		[873] link Ira Spetor, center=(658,951), url='https://www.sfatherapeutics.com/ira-spector'
			image Ira Spetor, url='https://static.wixstatic.com/media/abea01_5b2d0096af4c4375a7f4e71a8ffcf769~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Ira%20Spetor.jpg'
		heading IRA C. SPECTOR - PhD CEO, CO-FOUNDER
			link IRA C. SPECTOR - PhD CEO, CO-FOUNDER, url='https://www.sfatherapeutics.com/ira-spector'
				StaticText IRA C. SPECTOR
				StaticText -
				StaticText PhD
				StaticText CEO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/ira-spector-00414310/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link James Kirwin_edited_edited.jpg, url='https://www.sfatherapeutics.com/james-kirwin'
			image James Kirwin_edited_edited.jpg, url='https://static.wixstatic.com/media/abea01_999a95a454bb411db9cdcc7309fae2f3~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/James%20Kirwin_edited_edited.jpg'
		heading JAMES KIRWIN -MBA COO, CO-FOUNDER
			link JAMES KIRWIN -MBA COO, CO-FOUNDER, url='https://www.sfatherapeutics.com/james-kirwin'
				StaticText JAMES KIRWIN -MBA
				StaticText COO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/james-kirwin-79482914/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Steve King.jpg, url='https://www.sfatherapeutics.com/steve-king'
			image Steve King.jpg, url='https://static.wixstatic.com/media/abea01_9dbaa39d3eb54f738d9a299c81adfe3f~mv2.jpg/v1/crop/x_68,y_0,w_370,h_540/fill/w_187,h_273,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Steve%20King.jpg'
		heading STEVE KING HEAD OF CMC
			link STEVE KING HEAD OF CMC, url='https://www.sfatherapeutics.com/robert-dickey'
				StaticText STEVE KING
				StaticText HEAD OF CMC
		list Social Bar
			listitem
				link https://www.linkedin.com/in/steve-king-6534aa5/, url='https://www.linkedin.com/in/robdickey/'
					image https://www.linkedin.com/in/steve-king-6534aa5/, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		[936] link Mark Feitelson, center=(960,951), url='https://www.sfatherapeutics.com/mark-feitelson'
			image Mark Feitelson, url='https://static.wixstatic.com/media/abea01_c7ad8e0ce41b4ff5bf4b49e18a6614ba~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Mark%20Feitelson.jpg'
		heading MARK FEITELSON - PhD CSO, CO-FOUNDER
			link MARK FEITELSON - PhD CSO, CO-FOUNDER, url='https://www.sfatherapeutics.com/mark-feitelson'
				StaticText MARK FEITELSON - PhD
				StaticText CSO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/mark-feitelson-707771a/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link King Lee, url='https://www.sfatherapeutics.com/king-lee'
			image King Lee, url='https://static.wixstatic.com/media/abea01_824bb01538ce41048932315adf65cd41~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/King%20Lee.jpg'
		heading KING LEE - PhD HEAD OF REGULATORY AFFAIRS
			link KING LEE - PhD, url='https://www.sfatherapeutics.com/james-kirwin'
				StaticText KING LEE - PhD
			link HEAD OF REGULATORY AFFAIRS, url='https://www.sfatherapeutics.com/james-kirwin'
				StaticText HEAD OF REGULATORY AFFAIRS
		list Social Bar
			listitem
				link https://www.linkedin.com/in/king-lee-2541317/, url='https://www.linkedin.com/in/king-lee-2541317/'
					image https://www.linkedin.com/in/king-lee-2541317/, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Robert Dickey_edited.jpg, url='https://www.sfatherapeutics.com/robert-dickey'
			image Robert Dickey_edited.jpg, url='https://static.wixstatic.com/media/abea01_cc009c709f224bf89dfc09d7d168eeb2~mv2.jpg/v1/crop/x_95,y_0,w_1065,h_1600/fill/w_183,h_275,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Robert%20Dickey_edited.jpg'
		heading ROBERT DICKEY - BA MBA CFO
			link ROBERT DICKEY - BA MBA CFO, url='https://www.sfatherapeutics.com/robert-dickey'
				StaticText ROBERT DICKEY - BA MBA
				StaticText CFO
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/robdickey/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		[1004] link IMG_6520_edited.jpg, center=(1264,951), url='https://www.sfatherapeutics.com/alla-arzumanyan'
			image IMG_6520_edited.jpg, url='https://static.wixstatic.com/media/abea01_a6fc3f2598dd499ca2821e1f26da54f7~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6520_edited.jpg'
		heading ALLA ARZUMANYAN - PhD  CDO, CO-FOUNDER
			link ALLA ARZUMANYAN - PhD  CDO, CO-FOUNDER, url='https://www.sfatherapeutics.com/alla-arzumanyan'
				StaticText ALLA ARZUMANYAN - PhD
				StaticText CDO, CO-FOUNDER
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/alla-arzumanyan-66a79a18b/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Shawn O'Brien, url='https://www.sfatherapeutics.com/shawn-o-brien'
			image Shawn O'Brien, url="https://static.wixstatic.com/media/abea01_4f8ffc22876a465caaf810f15eaa97b1~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Shawn%20O'Brien.jpg"
		heading SHAWN O'BRIEN - MS MBA CHAIRMAN
			link SHAWN O'BRIEN - MS MBA CHAIRMAN, url='https://www.sfatherapeutics.com/shawn-o-brien'
				StaticText SHAWN O'BRIEN - MS MBA
				StaticText CHAIRMAN
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/shawn-patrick-o-brien/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		link Stefan Weiss, url='https://www.sfatherapeutics.com/stefan-weiss'
			image Stefan Weiss, url='https://static.wixstatic.com/media/abea01_fca81b48d7534b5bb2a2ea4c66ec9d50~mv2.jpg/v1/fill/w_183,h_276,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Stefan%20Weiss.jpg'
		heading STEFAN WEISS - MD CMO
			link STEFAN WEISS - MD CMO, url='https://www.sfatherapeutics.com/stefan-weiss'
				StaticText STEFAN WEISS - MD
				StaticText CMO
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/stefancweiss/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		heading SCIENTIFIC ADVISORY BOARD WITH RECOGNIZED KEY OPINION LEADERS
			StaticText SCIENTIFIC ADVISORY BOARD WITH
			StaticText RECOGNIZED KEY OPINION LEADERS
		image IMG_6297_edited.jpg, url='https://static.wixstatic.com/media/abea01_0604d9cb719a4cf195301f878b5b69c4~mv2.jpg/v1/fill/w_140,h_212,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6297_edited.jpg'
		heading SYLVIA HSU - MD DERMATOLOGY
			StaticText SYLVIA HSU - MD
			StaticText DERMATOLOGY
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/sylvia-hsu-9402a436/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		image IMG_6303.JPG, url='https://static.wixstatic.com/media/abea01_c7656f9a106a4238a3a98f9a91cc66d1~mv2.jpg/v1/fill/w_140,h_212,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6303_JPG.jpg'
		image IMG_6306_edited.jpg, url='https://static.wixstatic.com/media/abea01_4e2004b4d3ce404fbf659d033f641173~mv2.jpg/v1/fill/w_140,h_212,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6306_edited.jpg'
		image IMG_6350.JPG, url='https://static.wixstatic.com/media/abea01_a227d1caf6854c91a49b5a16edf2dcd7~mv2.jpg/v1/fill/w_141,h_214,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/IMG_6350_JPG.jpg'
		image SAUDER_edited.jpg, url='https://static.wixstatic.com/media/abea01_10288e3e34c54c22a982a1aef2e44375~mv2.jpg/v1/fill/w_141,h_214,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/SAUDER_edited.jpg'
		heading CHRIS GALLEN - MD PhD IMMUNOLOGY
			StaticText CHRIS GALLEN - MD PhD
			StaticText IMMUNOLOGY
		heading BRENT KORBA - PhD VIROLOGY & IMMUNOLOGY
			StaticText BRENT KORBA - PhD
		heading JOSEPH CAMARDO - MD INDEPENDENT MEDICAL
			StaticText JOSEPH CAMARDO - MD
			StaticText INDEPENDENT MEDICAL
		heading DANIEL N. SAUDER - MD, FRCPC, FACP DERMATOLOGY
			StaticText DANIEL N. SAUDER -
			StaticText MD, FRCPC, FACP
			StaticText DERMATOLOGY
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/christopher-gallen-919b48/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/brent-korba-462424126/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/joe-camardo-3540aa15/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/daniel-sauder-8ba66835/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		heading BUSINESS ADVISORY TEAM
			StaticText BUSINESS ADVISORY TEAM
		paragraph
			StaticText CRAIG KENESKY - PhD IP COUNSEL
		paragraph
		paragraph
			StaticText IP Counsel, Wilson-Sonsini-Goodrich-Rosati
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/craig-kenesky-ph-d-1ab03a6/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText JORDAN WARSHAFSKY - MBA
		paragraph
			StaticText ​
		paragraph
			StaticText Business/HR Advisor,Ashton Tweed
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/jordan-warshafsky/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText ANDREW GILBERT - JD
		paragraph
			StaticText ​
		paragraph
			StaticText Corporate Counsel, DLA Piper
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/andrew-gilbert-2a11a31/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText KATE HERMANS - MASTER OF INTL MGMT
		paragraph
			StaticText ​
		paragraph
			StaticText Business / Commercial Strategy Advisor
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/katehermans/'
					image LinkedIn, url='https://static.wixstatic.com/media/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_a06d85fa94d64ef68680321f5a043a8c~mv2.png'
		paragraph
			StaticText Ananda Gubbi - PhD
		paragraph
		paragraph
			StaticText Director of Biostatistics
		paragraph
			StaticText ANGELA LYNCH - PhD
		paragraph
			StaticText ​
		paragraph
			StaticText Pre-Clinical Development
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/betty-jean-swartz/'
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/in/angelalynchphdtoxplus/'
	contentinfo
		heading QUICK LINKS
			StaticText QUICK LINKS
		heading HOME
			link HOME, url='https://www.sfatherapeutics.com/'
				StaticText HOME
		image SFA Original Text Light, url='https://static.wixstatic.com/media/abea01_a9ae7b8182cc44c8a725294278f61e7f~mv2.png/v1/crop/x_0,y_33,w_590,h_134/fill/w_90,h_20,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/SFA%20Original%20Text%20Light.png'
		heading LOCATION
			StaticText LOCATION
		image Picture16.png, url='https://static.wixstatic.com/media/abea01_34572d42259d49b6a6f2697da2f4d2b3~mv2.png/v1/fill/w_109,h_102,al_c,q_85,usm_0.66_1.00_0.01,blur_3,enc_avif,quality_auto/Picture16.png'
		paragraph
			StaticText 610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
		heading PSORIASIS
			link PSORIASIS, url='https://www.sfatherapeutics.com/clinical'
				StaticText PSORIASIS
		heading CAREERS
			link CAREERS, url='https://www.sfatherapeutics.com/general-1'
				StaticText CAREERS
		heading CONTACT FORM
			link CONTACT FORM, url='https://www.sfatherapeutics.com/contact'
				StaticText CONTACT FORM
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/company/sfa-therapeutics/'
		paragraph
			StaticText 267-584-1080
		paragraph
			link info@sfatherapeutics.com, url='mailto:info@sfatherapeutics.com'
		paragraph
			StaticText 2024 by SFA THERAPEUTICS, INC.
		paragraph
			StaticText All Rights Reserved.
	region bottom of page
```
</details>



```
RootWebArea Ira Spector | Sfa Therapeutics 1, focused, url='https://www.sfatherapeutics.com/ira-spector'
	region top of page, focused
	button Skip to Main Content
	banner
		image Picture14.png, url='https://static.wixstatic.com/media/abea01_a79f1203843b4f1e869606561d1b7259~mv2.png/v1/crop/x_0,y_5,w_542,h_480/fill/w_99,h_88,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture14.png'
```
<details><summary>Show more</summary>

```
		image SFA Original Text.png, url='https://static.wixstatic.com/media/abea01_eddf156dbc904acf958c4ff6ba8dd10a~mv2.png/v1/crop/x_2,y_35,w_588,h_140/fill/w_332,h_79,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Original%20Text.png'
		heading TM
		navigation Site
			list
				listitem
					[115] link HOME, center=(520,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText HOME
				listitem
					[120] link ABOUT, center=(618,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText ABOUT
				listitem
					[125] link TEAM, center=(716,144), url='https://www.sfatherapeutics.com/team'
						paragraph
							StaticText TEAM
				listitem
					[130] link SCIENCE, center=(814,144), url='https://www.sfatherapeutics.com/science'
						paragraph
							StaticText SCIENCE
				listitem
					[135] link PLATFORM, center=(912,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText PLATFORM
				listitem
					[140] link PIPELINE, center=(1010,144), url='https://www.sfatherapeutics.com/pipeline'
						paragraph
							StaticText PIPELINE
				listitem
					[145] link CLINICAL, center=(1108,144), url='https://www.sfatherapeutics.com/clinical'
						paragraph
							StaticText CLINICAL
				listitem
					[150] link NEWS, center=(1206,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText NEWS
				listitem
					[158] link INVESTORS, center=(1304,144), url='https://www.sfatherapeutics.com/'
						paragraph
							StaticText INVESTORS
				listitem
					[163] link CONTACT, center=(1400,144), url='https://www.sfatherapeutics.com/contact'
						paragraph
							StaticText CONTACT
	main
		image Ira Spector, url='https://static.wixstatic.com/media/abea01_5b2d0096af4c4375a7f4e71a8ffcf769~mv2.jpg/v1/fill/w_588,h_759,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/abea01_5b2d0096af4c4375a7f4e71a8ffcf769~mv2.jpg'
		[1253] div, center=(960,764), inner_text=IRA SPECTOR - PhD
CHIEF EXECUTIVE OFFICER & CO-FOUNDER

Dr. Spector is a distinguished pharmaceutical and biotechnology executive with over 40 years of experience in drug development, clinical operations, and business leadership.

​

Prior to SFA Therapeutics, Dr. Spector held several executive positions at leading pharmaceutical companies, including ICON plc., Pfizer/Wyeth Research and Allergan.  He contributed to the development of 34 approved drugs, including Enbrel, Effexxor, Protonix, Prevenar-13, Mylotarg* at Wyeth/Pfizer, where he was Vice President of Clinical Operations and Vice-Chief of Development.  At Allergan, he helped develop Ozurdex for Diabetic Macular Edema and Retinal Venous Occlusion, Botox for Overactive Bladder, Botox for Chronic Migraine, Juvederm XL and Botox for Cerebral Palsy.

​

​​​Dr. Spector holds B.S. degrees in Physics and Electrical Engineering from Washington University, where he was a Langsdorf Fellow, an MBA from Drexel University, and a PhD in Health Sciences from Rutgers University, with a focus on biostatistics and epidemiology.​​​​
		heading IRA SPECTOR - PhD
			StaticText IRA SPECTOR - PhD
		list Social Bar
			listitem
				link Linkedin, url='https://www.linkedin.com/in/ira-spector-00414310/'
					image Linkedin, url='https://static.wixstatic.com/media/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_7cf73902d06c4f3685c379a21c6c8285~mv2.png'
		heading CHIEF EXECUTIVE OFFICER & CO-FOUNDER
		image SFA Logo V3, url='https://static.wixstatic.com/media/abea01_34572d42259d49b6a6f2697da2f4d2b3~mv2.png/v1/fill/w_110,h_103,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Logo%20V3.png'
		paragraph
			StaticText Dr. Spector is a distinguished pharmaceutical and biotechnology executive with over 40 years of experience in drug development, clinical operations, and business leadership.
		paragraph
			StaticText ​
		paragraph
			StaticText Prior to SFA Therapeutics, Dr. Spector held several executive positions at leading pharmaceutical companies, including ICON plc., Pfizer/Wyeth Research and Allergan.  He contributed to the development of 34 approved drugs, including Enbrel, Effexxor, Protonix, Prevenar-13, Mylotarg* at Wyeth/Pfizer, where he was Vice President of Clinical Operations and Vice-Chief of Development.  At Allergan, he helped develop Ozurdex for Diabetic Macular Edema and Retinal Venous Occlusion, Botox for Overactive Bladder, Botox for Chronic Migraine, Juvederm XL and Botox for Cerebral Palsy.
		paragraph
			StaticText ​
		paragraph
			StaticText ​
			StaticText ​
			StaticText ​
			StaticText Dr. Spector holds B.S. degrees in Physics and Electrical Engineering from Washington University, where he was a Langsdorf Fellow, an MBA from Drexel University, and a PhD in Health Sciences from Rutgers University, with a focus on biostatistics and epidemiology.
			StaticText ​
			StaticText ​
			StaticText ​
			StaticText ​
	contentinfo
		heading QUICK LINKS
			StaticText QUICK LINKS
		heading HOME
			link HOME, url='https://www.sfatherapeutics.com/'
				StaticText HOME
		image SFA Original Text Light, url='https://static.wixstatic.com/media/abea01_a9ae7b8182cc44c8a725294278f61e7f~mv2.png/v1/crop/x_0,y_33,w_590,h_134/fill/w_360,h_82,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SFA%20Original%20Text%20Light.png'
		heading LOCATION
			StaticText LOCATION
		image Picture16.png, url='https://static.wixstatic.com/media/abea01_34572d42259d49b6a6f2697da2f4d2b3~mv2.png/v1/fill/w_109,h_102,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Picture16.png'
		paragraph
			StaticText 610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
		heading PSORIASIS
			link PSORIASIS, url='https://www.sfatherapeutics.com/clinical'
				StaticText PSORIASIS
		heading CAREERS
			link CAREERS, url='https://www.sfatherapeutics.com/general-1'
				StaticText CAREERS
		heading CONTACT FORM
			link CONTACT FORM, url='https://www.sfatherapeutics.com/contact'
				StaticText CONTACT FORM
		list Social Bar
			listitem
				link LinkedIn, url='https://www.linkedin.com/company/sfa-therapeutics/'
					image LinkedIn, url='https://static.wixstatic.com/media/fcfebdfae12a44f993a94aeed8e2e66b.png/v1/fill/w_83,h_83,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/fcfebdfae12a44f993a94aeed8e2e66b.png'
		paragraph
			StaticText 267-584-1080
		paragraph
			link info@sfatherapeutics.com, url='mailto:info@sfatherapeutics.com'
		paragraph
			StaticText 2024 by SFA THERAPEUTICS, INC.
		paragraph
			StaticText All Rights Reserved.
	region bottom of page
```
</details>

**Reasoning for action:** Since the user is interested in learning about the key personnel at SFA Therapeutics, clicking on Ira Spector's profile is the logical next step. This action directly leads to the content that includes his role as CEO and co-founder, along with his professional biography. Gathering this information is essential for the user to evaluate the team before making an investment decision.

**Action:** click(873) # Click on the link for Ira Spetor to learn more about his background and role.

**Change Description:** The browser navigated from the 'TEAM' page of SFA Therapeutics to the 'Ira Spector' page, displaying detailed information about Dr. Spector, including his role as CEO and co-founder, along with a personal biography and his professional background.

**Screenshot before:****Screenshot after:**---

